Relation of waveform of transit-time flow measurement and graft patency in coronary artery bypass grafting  by Hatada, Atsutoshi et al.
Brief
Communications
Relation of waveform of transit-time flow measurement and graft
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Graft patency is the major factor limiting the initial clinical benefits of revascu-larization and patient survival; however, it is not easy to anticipate. Transit-timeflow measurement (TTFM) has been the common method of assessing intraop-erative coronary artery bypass grafting (CABG) patency because it is a nonin-
vasive and easy method. TTFM provides a mean graft flow (MGF), a flow waveform, and
derived values such as the pulsatility index (PI). D’Ancona and colleagues1 reported the
necessity to revise 3% of grafts on the basis of TTFM and emphasized the crucial feature of
flow value interpretation as an index of graft patency. Takami and Ina2 reported the relation
between the graft flow waveform and the anastomotic quality of CABG using a fast Fourier
transformation (FFT) analysis. However, there have been no reports that graft patency can be
anticipated using analysis of the graft flow waveform.
We demonstrate that graft patency can be assessed with FFT analysis of TTFM waveform.
Clinical Summary
The present study included 29 patients who underwent isolated CABG with cardiopulmonary
bypass and a postoperative cardiac catheterization (the term after CABG; 3–6 months). The
patients received 29 saphenous vein grafts, all aortocoronary bypass grafts, including 24
patent grafts in the future and 5 occluded grafts. All anastomoses were performed by 1
surgeon (Y. O.) in the same fashion.
Graft flow tracing was obtained intraoperatively using a transit-time flowmeter (BF 1000;
Medi-Stim AS, Oslo, Norway). A flow probe to fit each saphenous vein graft (3–4 mm) was
placed around the graft when hemodynamic conditions were stable after weaning from
CABG. On the basis of the obtained flow profile, the following variables were calculated:
MGF, PI, and FFT of the flow waveform. Harmonics of FFT analysis by the flowmeter
existed at frequencies that were multiplies of the frequency of the original waveform and were
described in terms of an amplitude and a phase. In the present study, we defined F0 as a power
of the fundamental frequency, H1 as a power of the first harmonic, H2 as a power of the
second harmonic, and sequentially as H3, H4, H5, H6, H7, H8, H9, and H10. Ha (H5  H6
 H7  H8  H9  H10) was calculated.
All data were expressed as mean standard division. Comparison of the data between the
patent and occluded grafts was performed using the Student t test.
Results
Figure 1 shows the PI and MGF of each group (patent grafts and occluded grafts). There was
no significant difference between the patent grafts and occluded grafts (PI: 27.2  16.6 vs
21.0  10.9, respectively, P  .181; MGF: 3.60  2.23 vs 4.91  4.69, respectively, P 
.155). Figure 2 shows the power of Ha. In the spectrum from H5 to H10, the power in the
group of patent grafts was significantly higher than that in the group of occluded grafts. Ha
in the group of patent grafts was significantly higher than that in the group of occluded grafts
(0.352  0.0517 vs 0.485  0.402, respectively, P  .04).
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Discussion
D’Ancona and colleagues1 emphasized the reliance on correct
analysis of TTFM flow patterns to correct abnormalities and re-
ported a predominantly systolic flow in 34 of 37 grafts, which had
altered to a diastolic pattern after revision. The flow pattern was
useful to confirm graft patency in conjunction with adequate MGF
and PI values. In this study, MGF and PI values were not signif-
icantly different between the patent grafts and the nonpatent grafts.
Some reports3,4 demonstrated that graft flow waveform was more
important in relation to graft patency than graft flow volume,
because graft flow waveform affects the perfusion area of target
vessels, coronary resistance, graft resistance, and quality of anas-
tomosis. We did not consider the quality of anastomosis because
our study did not include the grafts with anastomotic stenosis.
In contrast, although it was reported that the diastolic filling
pattern was a good graft flow waveform,5 no study has reported that
pattern expressed as the numeric value. We demonstrated graft flow
waveform expressed as the numeric value using FFT analysis, and
harmonics of FFT analysis may become the parameter to express graft
patency when comparing patent grafts with nonpatent grafts.
We did not report the cutoff value of the parameter including H5,
H6, H7, H8, H9, H10, and Ha. Because the graft flow waveform was
different in each kind of graft, including the internal thoracic artery,
gastroepiploic artery, radial artery, and saphenous vein, we should
investigate the parameters in each kind of graft in the future.
Conclusions
We demonstrated that graft patency may be anticipated using FFT
analysis of TTFM waveform.
We acknowledge the technical assistance of Ryota Tsubaki, a
graduate student of Kobe University.
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Figure 1. Comparison of PI and MGF
between patent and nonpatent grafts.
Bars show mean  SD. PI, Pulsatility
index; MGF, mean graft flow.
Figure 2. Comparison of Ha between patent and nonpatent grafts.
Bars show mean  SD. *P  .04.
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Intermittent incomplete closure of Medtronic Advantage aortic valve
leaflets causes unnecessary reoperation
Rune Haaverstad, MD, PhD,a,c Nicola Vitale, MD, PhD,a,c Arve Tromsdal, MD,a,b Knut Hegbom, MD,b and
Asbjørn Karevold, MD,a Trondheim, Norway
A40-year-old man underwent isolated aortic valve re-placement with a 23-mm Medtronic Advantage valveprosthesis (Medtronic, Minneapolis, Minn) for severestenosis of a bicuspid aortic valve. The valve was
implanted with pledgets by the non-everting suture technique and
placed with the central orifice pointing in between the coronary
ostia. The postoperative course was uneventful, and the patient
was discharged on the sixth postoperative day. Control transtho-
racic echocardiograms were performed before discharge and 6 and
12 months after discharge, all of which showed a normal func-
tioning prosthetic valve with a mean gradient of 12 mm Hg. The
patient was in New York Heart Association functional class I and
had resumed all his activities within the follow-up.
Clinical Summary
Two years after surgery and 1 year after the last echocardiogram,
the patient had occasional transient memory losses and disturbed
vision, which were consistent with thromboembolism because they
were associated with a nontherapeutic international normalized
ratio (INR) of 1.3. The patient underwent hemorrhoid surgery
during the same period, which contributed to keep the INR level
well below the desired 2.5 to 3.5 range. At the routine 2-year
follow-up control (25.5 months after valve implantation), the pa-
tient was in good health and asymptomatic, despite a diastolic
murmur of variable intensity on auscultation. The transthoracic
echocardiogram revealed an intermittent and incomplete closure
of the prosthetic leaflet, causing single-beat valve regurgitation
of a degree varying from 1 to 3. The mean transvalvular
gradient was 14 mm Hg. The transesophageal echocardiogram
confirmed these findings. The patient then underwent fluoroscopy;
during the investigation the patient was in sinus rhythm, as usual,
and no ectopic ventricular beats were recorded. Fluoroscopy
showed intermittent incomplete closure of both valve leaflets (Fig-
ure 1). An incomplete closure of the anterior leaflet occurred
approximately every 10 beats; this appeared to create a minor gap
between the inner side of the ring and the leaflet edge, most likely
causing a trivial regurgitation (Figure 1, A). In addition, a closure
delay of the posterior leaflet was caught just once during film
recording. In this position, it was discovered that the posterior
leaflet stood open at approximately 90 degrees from the valve ring
while the anterior leaflet was closed (Figure 1, B). We believe this
phenomenon is responsible for the 3 regurgitation noted on the
echocardiograms.
On the basis of the patient history and investigations, the cause
of the prosthetic malfunction was assumed to be an obstruction
limiting leaflet excursions; therefore, the patient underwent reop-
eration the following day. During surgical exploration, no pannus
or thrombus was found on or around the valve; the valve was
normal in appearance and function, and both leaflets had free
movement. No subvalvular tissue was seen bulging into the hinge
mechanism, and the valve was left in place.
The postoperative course was uneventful, and the patient was
discharged. At the last control in March 2007, the patient was still
in New York Heart Association class I and totally asymptomatic;
his INR level was stable between 2.5 and 3.5. The transthoracic
echocardiography showed a mean gradient of 12 mm Hg and an
intermittent incomplete closure of 1 leaflet in approximately 15%
of the strokes, determining transient, single-beat, trivial-to-mild
regurgitation.
Discussion
This case report is in line with previous articles from Munich in
which a total of 7 cases of intermittent regurgitation of a Medtronic
Advantage aortic valve were observed.1,2 Unfortunately, in our
case there were several confounding factors that led us to believe
the incomplete closure was caused by a thrombotic obstruction,
and the patient underwent reoperation. First, there was a transient
ischemic attack associated with a prolonged period of a low INR
level, which was then followed by concomitant recent hemorrhoid
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